OBIO · Orchestra BioMed Holdings, Inc. · Executive Compensation
$6.11
+0.29 (+5.00%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$349.81M
Shares
60.11M
Volume · Oct 20
992.78K
Avg daily vol (3M)
316.67K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Eric Rose, M.D. | Board | Resigned | 2025-02-05 |
| Chris Cleary | Class II director | Appointed | 2025-02-05 |
| John Mack | Class I director | Appointed | 2024-07-30 |
| Andrew Taylor | Chief Financial Officer | Appointed | 2023-06-08 |
| Darren R. Sherman | Director | Appointed | 2023-01-31 |
| David Hochman | Director | Appointed | 2023-01-31 |
| David Hochman | Chief Executive Officer and Orchestra BioMed Founder | Appointed | 2023-01-31 |
| Darren R. Sherman | President and Chief Operating Officer | Appointed | 2023-01-31 |
| Yuval Mika, Ph.D. | General Manager and Chief Technology Officer, Bioelectronic Therapies | Appointed | 2023-01-31 |
| Michael D. Kaswan | Chief Financial Officer | Appointed | 2023-01-31 |
| Eric S. Fain, M.D. | Class III director | Appointed | 2023-01-31 |
| David P. Hochman | Chief Executive Officer | Appointed | 2023-01-31 |
| Darren R. Sherman | Class III director | Appointed | 2023-01-31 |
| David P. Hochman | Class III director | Appointed | 2023-01-31 |
| Geoffrey W. Smith | Class II director | Appointed | 2023-01-31 |
| Pamela Y. Connealy | Class II director | Appointed | 2023-01-31 |
| Jason Aryeh | Class I director | Appointed | 2023-01-31 |
| Eric A. Rose, M.D. | Class I director | Appointed | 2023-01-31 |
| Eric S. Fain, M.D. | director | Appointed | 2023-01-25 |
| Darren R. Sherman | director | Appointed | 2023-01-25 |
| David P. Hochman | director | Appointed | 2023-01-25 |
| Jason Aryeh | director | Appointed | 2023-01-25 |
| Pamela Y. Connealy | director | Appointed | 2023-01-25 |
| Geoffrey W. Smith | director | Appointed | 2023-01-25 |
| Eric A. Rose, M.D. | director | Appointed | 2023-01-25 |
Leadership
- David Hochman CEO, Board Member
- David P. Hochman CEO, Board Member
- Andrew L. Taylor CFO
- Andrew Taylor CFO
- Michael D. Kaswan CFO
- Darren R. Sherman COO, Board Member
- Yuval Mika CTO
- Yuval Mika, Ph.D. CTO
- Chris Cleary Board Member
- Continuing Directors Board Member
- David Pacitti Board Member
- Eric A. Rose, M.D. Board Member
- Eric S. Fain Board Member
- Eric S. Fain, M.D. Board Member
- Geoffrey W. Smith Board Member
- Jason Aryeh Board Member
- John Mack Board Member
- Pamela A. Connealy Board Member
- Pamela Y. Connealy Board Member